Evidence map›Paper›PMID 33059160›Full record

ArticleCancer genetics2020

CytoGPS: A large-scale karyotype analysis of CML data.

Zachary B Abrams, Suli Li, Lin Zhang, Caitlin E Coombes, Philip R O Payne, Nyla A Heerema, Lynne V Abruzzo, Kevin R Coombes

Abstract read
In one paragraph

Article in Cancer genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zachary B AbramsDepartment of Biomedical Informatics, Wexner Medical Center, The Ohio State University, 250 Lincoln Tower, 1800 Cannon Drive, Columbus, OH 43210, USA. Electronic address: Zachary.Abrams@osumc.edu.
Suli LiDepartment of Biomedical Informatics, Wexner Medical Center, The Ohio State University, 250 Lincoln Tower, 1800 Cannon Drive, Columbus, OH 43210, USA.
Lin ZhangInstitute for Informatics, Washington University School of Medicine in St. Louis, St. Louis, MO 63108, USA.
Caitlin E CoombesDepartment of Biomedical Informatics, Wexner Medical Center, The Ohio State University, 250 Lincoln Tower, 1800 Cannon Drive, Columbus, OH 43210, USA.
Philip R O PayneInstitute for Informatics, Washington University School of Medicine in St. Louis, St. Louis, MO 63108, USA.
Nyla A HeeremaDepartment of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH 43210, USA.
Lynne V AbruzzoDepartment of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH 43210, USA.
Kevin R CoombesDepartment of Biomedical Informatics, Wexner Medical Center, The Ohio State University, 250 Lincoln Tower, 1800 Cannon Drive, Columbus, OH 43210, USA. Electronic address: kevin.coombes@osumc.edu.

Funding

The OSU Clinical and Translational Research Informatics Training Program (CTRIP)T15LM011270 · NLM · OHIO STATE UNIVERSITY · PI COOMBES, KEVIN ROBERT, JANIES, DANIEL A. · 2012 to 2016
$2.2M
Secondary Use of Karyotype Data to Predict Outcomes in CLLR03CA235101 · NCI · OHIO STATE UNIVERSITY · PI COOMBES, KEVIN ROBERT · 2019 to 2020
$156k
NCI NIH HHS R03 CA235101NLM NIH HHS T15 LM011270
6 · The paper itself

Abstract

Karyotyping, the practice of visually examining and recording chromosomal abnormalities, is commonly used to diagnose diseases of genetic origin, including cancers. Karyotypes are recorded as text written in the International System for Human Cytogenetic Nomenclature (ISCN). Downstream analysis of karyotypes is conducted manually, due to the visual nature of analysis and the linguistic structure of the ISCN. The ISCN has not been computer-readable and, as such, prevents the full potential of these genomic data from being realized. In response, we developed CytoGPS, a platform to analyze large volumes of cytogenetic data using a Loss-Gain-Fusion model that converts the human-readable ISCN karyotypes into a machine-readable binary format. As proof of principle, we applied CytoGPS to cytogenetic data from the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, a National Cancer Institute hosted database of over 69,000 karyotypes of human cancers. Using the Jaccard coefficient to determine similarity between karyotypes structured as binary vectors, we were able to identify novel patterns from 4,968 Mitelman CML karyotypes, such as the co-occurrence of trisomy 19 and 21. The CytoGPS platform unlocks the potential for large-scale, comparative analysis of cytogenetic data. This methodological platform is freely available at CytoGPS.org.

Indexed as

AlgorithmsChromosome AberrationsChromosomes, HumanDatabases, FactualCytogenetic AnalysisHumansKaryotypingLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrognosisBioinformaticsChronic myeloid leukemiaCytogeneticsCytoGPSData scienceKaryotypes

Identifiers

PMID33059160
PMCPMC8126981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.